Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.

Publikation

Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.

Wissenschaftlicher Artikel/Review - 28.08.2014

De Marchis Gian Marco, Weck Anja, Audebert Heinrich J, Benik Steffen, Foerch Christian, Buhl Daniela, Schuetz Philipp, Jung Simon, Seiler Marleen, Morgenthaler Nils G, Mattle Heinrich Paul, Müller-Stich Beat P, Christ-Crain Mirjam, Arnold Marcel, Katan Mira

Zitation

De Marchis G, Weck A, Audebert H, Benik S, Foerch C, Buhl D, Schuetz P, Jung S, Seiler M, Morgenthaler N, Mattle H, Müller-Stich B, Christ-Crain M, Arnold M, Katan M. Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study. Stroke 2014; 45:2918-23.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Stroke 2014; 45

Veröffentlichungsdatum

28.08.2014

eISSN (Online)

1524-4628

Seiten

2918-23

Kurzbeschreibung/Zielsetzung

Copeptin has been associated with recurrent cerebrovascular events after transient ischemic attack (TIA). In an independent cohort, we evaluated copeptin for the prediction of recurrent cerebrovascular events within 3 months after TIA and assessed the incremental value of copeptin compared with the ABCD2 (age, blood, clinical features of TIA, duration of symptoms, presence of diabetes mellitus) and ABCD3-I (ABCD2, dual TIA [the presence of ≥2 TIA symptoms within 7 days], imaging [the presence of abnormal findings on neuroimaging]) scores.